Amvuttra Side Effects
Generic name: vutrisiran
Medically reviewed by Drugs.com. Last updated on Oct 30, 2023.
Note: This document provides detailed information about Amvuttra.
Applies to vutrisiran: subcutaneous solution Side Effects associated with vutrisiran. Some dosage forms listed on this page may not apply specifically to the brand name Amvuttra.
Applies to vutrisiran: subcutaneous solution.
Precautions
It is very important that your doctor check your progress at regular visits to make sure that this medicine is working properly. Blood tests may be needed to check for unwanted effects.
This medicine may lower the vitamin A levels in your body, which may cause eye or vision problems (eg, night blindness, blurred vision, difficulty with reading, or any other change in vision). Your doctor may want your eyes be checked by an ophthalmologist (eye doctor).
Serious side effects of Amvuttra
Along with its needed effects, vutrisiran (the active ingredient contained in Amvuttra) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking vutrisiran:
More common side effects
- blurred or change in vision
- chest tightness
- difficulty with reading
- muscle pain or stiffness
- night blindness
- pain in the arms, legs, or joints
- trouble breathing
Less common side effects
- chest pain
- dizziness
- fainting
- pounding, slow heartbeat
- unusual tiredness or weakness
Other side effects of Amvuttra
Some side effects of vutrisiran may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Less common side effects
For healthcare professionals
Applies to vutrisiran: subcutaneous solution.
General adverse events
The most common adverse reactions were pain in extremity, arthralgia, dyspnea, and decrease in vitamin A levels.[Ref]
Cardiovascular
- Common (1% to 10%): Atrioventricular heart block[Ref]
Local
Metabolic
- Very common (10% or more): Decreased vitamin A (80%)
- Common (1% to 10%): Increased blood alkaline phosphatase[Ref]
Musculoskeletal
- Very common (10% or more): Pain in extremity (15%), arthralgia (11%)[Ref]
Respiratory
- Common (1% to 10%): Dyspnea[Ref]
See also:
Vyndamax
Vyndamax may be given to reduce death or hospitalization caused by heart problems in adults with ...
Attruby
Attruby (acoramidis) tablets are used to treat cardiomyopathy of wild-type or hereditary ...
Wainua
Wainua (eplontersen) is used to treat polyneuropathy of hereditary transthyretin-mediated ...
Tegsedi
Tegsedi (inotersen) is an RNA-targeting treatment that may be used to reduce the symptoms of ...
Vyndaqel
Vyndaqel (tafamidis meglumine) is a transthyretin stabilizer that may be given to reduce death or ...
Onpattro
Onpattro is used to treat polyneuropathy in adults with hereditary transthyretin-mediated ...
Eplontersen
Eplontersen (Wainua) is used to treat polyneuropathy of hereditary transthyretin-mediated ...
Patisiran
Patisiran (brand name Onpattro) is an injectable treatment for polyneuropathy caused by hereditary ...
Acoramidis
Acoramidis systemic is used for cardiomyopathy of transthyretin-mediated amyloidosis
References
1. (2022) "Product Information. Amvuttra (vutrisiran)." Alnylam Pharmaceuticals, 1
2. (2022) "Product Information. Amvuttra (vutrisiran)." Alnylam UK Ltd
3. (2025) "Product Information. Amvuttra (vutrisiran)." Alnylam UK Ltd
4. (2024) "Product Information. Amvuttra (vutrisiran)." Medison Pharma Australia Pty Ltd
More about Amvuttra (vutrisiran)
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous metabolic agents
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Amvuttra side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.